Cleared Traditional

K190904 - Conformis BeneFIT Hip System

K190904 is the FDA 510(k) clearance for Conformis BeneFIT Hip System by Conformis, Inc.. It is a Class 2 Orthopedic device (product code LPH) cleared through the Traditional 510(k) pathway after a 142-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2019
Decision
142d
Days
Class 2
Risk

K190904 is an FDA 510(k) clearance for the Conformis BeneFIT Hip System. Classified as Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented (product code LPH), Class II - Special Controls.

Submitted by Conformis, Inc. (Billerica, US). The FDA issued a Cleared decision on August 28, 2019 after a review of 142 days - within the typical 510(k) review window.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3358 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Conformis, Inc. devices

Submission Details

510(k) Number K190904 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 08, 2019
Decision Date August 28, 2019
Days to Decision 142 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
20d slower than avg
Panel avg: 122d · This submission: 142d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LPH Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3358
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - LPH Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented

All 446
Devices cleared under the same product code (LPH) and FDA review panel - the closest regulatory comparables to K190904.
REDAPT Blade Augments
K190847 · Smith & Nephew, Inc. · Oct 2019
Trident II Acetabular System
K191358 · Howmedica Osteonics Corp. A.K.A. Stryker Orthopaedics · Oct 2019
iNSitu Total Hip System
K192071 · Theken Companies, LLC · Aug 2019
iNSitu Total Hip System
K191936 · Thecken Companies, LLC · Aug 2019
Medtronic Total Hip Arthroplasty System
K183129 · Medtronic Advanced Energy · Jul 2019
MicroPort CoCr Femoral Heads
K190123 · Microport Orthopedics, Inc. · Jul 2019